Sign in

    Robert M. Davis

    Chairman, CEO, and President at MMerck & Co Inc
    Board
    Since December 2022
    Age
    58 years
    Tenure
    Joined Merck & Co., Inc. in 2014 and has held multiple leadership roles, progressing from CFO and Executive Vice President roles to serving as CEO and ultimately assuming the roles of Chairman, CEO, and President in December 2022.

    Also at Merck & Co Inc

    BDL
    Betty D. Larson
    EVP and Chief Human Resources Officer
    CL
    Caroline Litchfield
    EVP and Chief Financial Officer
    CG
    Chirfi Guindo
    Chief Marketing Officer

    About

    Robert M. Davis is 58 years old as of February 1, 2025, and has established himself as a key leader at Merck & Co., Inc. Not much personal background is available beyond his age, and no details regarding his education have been provided.

    After joining Merck in 2014, he embarked on a rapid career progression. He held pivotal roles including Chief Financial Officer and Executive Vice President, and later advanced to become CEO and President from July 2021 until December 2022. In December 2022, he took on the additional responsibilities as Chairman, reflecting his significant contributions across the company.

    Beyond his roles at Merck, he has also demonstrated leadership in other capacities, notably serving on the Board of Directors at Duke Energy since 2018, where he contributes to critical governance matters. His experience from previous positions at Baxter International further supports his comprehensive understanding of the corporate and financial environments, rounding out his professional profile.

    $MRK Performance Under Robert M. Davis

    Past Roles

    OrganizationRoleDate RangeDetails
    Merck & Co., Inc. Chief Executive Officer and President July 2021 – December 2022 Former position before current role
    Merck & Co., Inc. Executive Vice President, Global Services, and Chief Financial Officer April 2016 – July 2021 Held prior to appointment as Chairman, CEO & President
    Merck & Co., Inc. Chief Financial Officer and Executive Vice President 2014 – 2016 Previous senior finance leadership role
    Baxter International, Inc. Corporate Vice President and President, Medical Products 2010 – 2014 Held leadership in medical products
    Baxter International, Inc. Corporate Vice President and Chief Financial Officer 2006 – 2010 Oversaw financial operations
    Baxter International, Inc. Corporate Vice President and Treasurer 2004 – 2006 Managed treasury functions

    External Roles

    Organization Role Date Range Details
    Duke Energy Board of Directors N/A Chair of the Finance & Risk Management Committee; Member of the Corporate Governance Committee

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary$1,603,091 AnnuallyFixed base salary
    Financial/Tax Counseling & Tax Preparation$10,000 As IncurredPart of All Other Compensation
    Company Aircraft$91,519 As IncurredPart of All Other Compensation
    Company Car and Driver$15,224 As IncurredPart of All Other Compensation
    Home Security (Installation/Maintenance)$11,824 As IncurredPart of All Other Compensation
    Savings Plan Company Match and Credits$257,580 As IncurredPart of All Other Compensation

    Performance Compensation

    Data from  FY 2023

    Annual Incentive (Cash-Based)

    MetricDetails
    Base Salary$1,615,000
    Target Incentive (150%)$2,422,500
    Company Scorecard Result148%
    Final Award$3,585,300
    Vesting ScheduleImmediate payout based on 2023 performance
    Evaluation Period2023 (annual)

    Long-Term Incentive (LTI)

    ComponentGrant DateGrant Date Fair ValueGrant Date Stock PriceTarget/Maximum SharesPerformance MetricsVesting Schedule
    Performance Share Units (PSUs)March 31, 2023$9,997,585 N/ATarget: 88,824 shares; Max: 177,648 shares 50% Three-Year Cumulative EPS & 50% Relative TSR; EPS thresholds: Threshold: $19.53 (25%), Target: $21.46 (100%), Stretch: $24.04 (200%) Vest at end of three-year performance period
    Stock OptionsMay 2, 2023$4,050,000 $117.89 N/AValue realized if stock price exceeds grant price; no additional performance thresholds provided Vest in three equal annual installments

    Note: Pro-rata Annual Cash Incentive details are integrated into the Annual Incentive component above. All performance payouts are determined based on the Company Scorecard and related pre-determined metrics.